Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
MoonLake Immunotherapeutics (MLTX)
NASDAQ:MLTX
RESEARCH TOOLSreports
MoonLake Immunotherapeutics (MLTX) Stock Price & Analysis
85 Followers
MLTX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$7.05 - $63.40
Previous Close$57.38
Volume780.09K
Average Volume (3M)504.13K
Market Cap
$3.07B
Enterprise Value$2.58B
Total Cash (Recent Filing)$501.79M
Total Debt (Recent Filing)$211.24K
Price to Earnings (P/E)-55.1
Beta0.78
Next Earnings
Nov 13, 2023EPS Estimate
-$0.23Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.04
Shares Outstanding62,446,005
10 Day Avg. Volume767,403
30 Day Avg. Volume504,134
Standard Deviation0.22
R-Squared0.11
Alpha0.06
Financial Highlights & Ratios
Price to Book (P/B)6.97
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-1.12K
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-45.54
Forecast
1Y Price Target
$70.89Price Target Upside18.31% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering10
MoonLake Immunotherapeutics News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
MLTX FAQ
What was MoonLake Immunotherapeutics’s price range in the past 12 months?
MoonLake Immunotherapeutics lowest stock price was $7.05 and its highest was $63.40 in the past 12 months.
What is MoonLake Immunotherapeutics’s market cap?
Currently, no data Available
When is MoonLake Immunotherapeutics’s upcoming earnings report date?
MoonLake Immunotherapeutics’s upcoming earnings report date is Nov 13, 2023 which is in 25 days.
How were MoonLake Immunotherapeutics’s earnings last quarter?
MoonLake Immunotherapeutics released its earnings results on Aug 10, 2023. The company reported -$0.23 earnings per share for the quarter, beating the consensus estimate of -$0.266 by $0.036.
Is MoonLake Immunotherapeutics overvalued?
According to Wall Street analysts MoonLake Immunotherapeutics’s price is currently Undervalued.
Does MoonLake Immunotherapeutics pay dividends?
MoonLake Immunotherapeutics does not currently pay dividends.
What is MoonLake Immunotherapeutics’s EPS estimate?
MoonLake Immunotherapeutics’s EPS estimate is -$0.23.
How many shares outstanding does MoonLake Immunotherapeutics have?
MoonLake Immunotherapeutics has 53,486,810 shares outstanding.
What happened to MoonLake Immunotherapeutics’s price movement after its last earnings report?
MoonLake Immunotherapeutics reported an EPS of -$0.23 in its last earnings report, beating expectations of -$0.266. Following the earnings report the stock price went up 0.553%.
Which hedge fund is a major shareholder of MoonLake Immunotherapeutics?
Among the largest hedge funds holding MoonLake Immunotherapeutics’s share is Woodline Partners LP. It holds MoonLake Immunotherapeutics’s shares valued at 3M.
---
MoonLake Immunotherapeutics Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$70.89 (18.31% Upside)
$70.89 (18.31% Upside)
Blogger Sentiment
Bullish
MLTX Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 393.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $20.3M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▼ 1.1%
Last 30 Days ▲ 4.2%
Last 30 Days ▲ 4.2%
News Sentiment
Very Positive
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
507.19%
12-Months-Change
Fundamentals
Return on Equity
-14.86%
Trailing 12-Months
Asset Growth
414.68%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
MoonLake Immunotherapeutics
Helix Acquisition Corp is a blank check company.
---
Top 5 ETFs holding MLTX
Invesco DWA Healthcare Momentum ETF
$4.65M
Fidelity Nasdaq Composite Index ETF
$678.35K
Fidelity MSCI Health Care Index ETF
$503.60K
Fidelity Blue Chip Growth ETF
$386.58K
Harbor Health Care ETF
$49.75K
Up to five ETFs with an Outperform Smart Score that hold MLTX. The ETFs are listed according to market value of MLTX within the ETF
---